Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
Condition or disease
Drug: Nanomilled testosteroneDrug: commercially available dutasterideDrug: Nanomilled dutasteride
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 50 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Have a BMI within range of 19-32 kg/m2.
Have not taken dutasteride for one year, or finasteride for the past 3 months.
Have a screening PSA < 2.0ng/mL.
Have had or have breast or prostate cancer, sleep apnea, psychiatric illness, or any other clinically significant current condition.
Have a trigliceride level =500mg/dL.
Have abnormal thyroid or hormone levels.
Would donate more than 500 ML of blood over a 2 month period.
Physician does not think it is a good idea for you to participate in the trial.
Are unwilling to abstain from alcohol during the study.
Have a positive urine drug screen test.
Plan to change your smoking habits during the course of the trial.
Have Hepatitis C, Hepatitis B, or HIV.
Have a lab or ECG abnormality.
Have high or low blood pressure.
Have used of any investigational drug or device during the study or within 30 days prior to 1st dosing of study medication.